-+ 0.00%
-+ 0.00%
-+ 0.00%

Piper Sandler Initiates Coverage On ORIC Pharmaceuticals with Overweight Rating, Announces Price Target of $22

Benzinga·01/07/2026 13:04:08
語音播報
Piper Sandler analyst Kelsey Goodwin initiates coverage on ORIC Pharmaceuticals (NASDAQ:ORIC) with a Overweight rating and announces Price Target of $22.